These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2058 related articles for article (PubMed ID: 32732090)
41. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891 [TBL] [Abstract][Full Text] [Related]
42. Extent of lateral neck dissection for papillary thyroid microcarcinomas. Lee JH; Chun YS; Chung YS Head Neck; 2019 May; 41(5):1367-1371. PubMed ID: 30536753 [TBL] [Abstract][Full Text] [Related]
43. Risk Factors for Central and Lateral Lymph Node Metastases in Patients With Papillary Thyroid Micro-Carcinoma: Retrospective Analysis on 484 Cases. Huang Y; Yin Y; Zhou W Front Endocrinol (Lausanne); 2021; 12():640565. PubMed ID: 33746905 [TBL] [Abstract][Full Text] [Related]
45. Bilateral multifocality, a marker for aggressive disease, is not an independent prognostic factor for papillary thyroid microcarcinoma: A propensity score matching analysis. Yan T; Qiu W; Song J; Ying T; Fan Y; Yang Z Clin Endocrinol (Oxf); 2021 Jul; 95(1):209-216. PubMed ID: 33660317 [TBL] [Abstract][Full Text] [Related]
46. Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas. Zhao L; Sun X; Luo Y; Wang F; Lyu Z Ann Diagn Pathol; 2020 Dec; 49():151647. PubMed ID: 33126150 [TBL] [Abstract][Full Text] [Related]
47. Risk Factors for Nodal Metastasis in cN0 Papillary Thyroid Microcarcinoma. Zhang LY; Liu ZW; Liu YW; Gao WS; Zheng CJ Asian Pac J Cancer Prev; 2015; 16(8):3361-3. PubMed ID: 25921145 [TBL] [Abstract][Full Text] [Related]
48. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer. Wang F; Yu X; Shen X; Zhu G; Huang Y; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Liu S; Zhao J; Zhao S; Xing M J Clin Endocrinol Metab; 2017 Sep; 102(9):3241-3250. PubMed ID: 28582521 [TBL] [Abstract][Full Text] [Related]
49. Nomogram for Preoperative Estimation of Cervical Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma. Sun J; Jiang Q; Wang X; Liu W; Wang X Front Endocrinol (Lausanne); 2021; 12():613974. PubMed ID: 33868164 [TBL] [Abstract][Full Text] [Related]
50. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma. Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368 [TBL] [Abstract][Full Text] [Related]
51. Determine the Optimal Extent of Thyroidectomy and Lymphadenectomy for Patients With Papillary Thyroid Microcarcinoma. Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z Front Endocrinol (Lausanne); 2019; 10():363. PubMed ID: 31275239 [No Abstract] [Full Text] [Related]
52. Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2,309 consecutive patients. Kim KJ; Kim SM; Lee YS; Chung WY; Chang HS; Park CS Ann Surg Oncol; 2015 Jan; 22(1):125-31. PubMed ID: 25092159 [TBL] [Abstract][Full Text] [Related]
53. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma? Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730 [TBL] [Abstract][Full Text] [Related]
54. A comparison of logistic regression and artificial neural networks in predicting central lymph node metastases in papillary thyroid microcarcinoma. Ozden S; Er S; Saylam B; Yildiz BD; Senol K; Tez M Ann Ital Chir; 2018; 89():193-198. PubMed ID: 30588918 [TBL] [Abstract][Full Text] [Related]
55. Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, lymphovascular invasion, extrathyroidal extension to the strap muscles, or five or more central lymph node micrometastasis. Beom Heo D; Piao Y; Hee Lee J; Ju SH; Yi HS; Su Kim M; Won HR; Won Chang J; Seok Koo B; Eun Kang Y Oral Oncol; 2022 Nov; 134():106115. PubMed ID: 36108524 [TBL] [Abstract][Full Text] [Related]
56. Prognostic factors for aggressiveness in subcentimeter papillary thyroid carcinoma: impact of tumor size and lymph node metastases. Kayhan Y; Azizova L; Yılmaz M; Bakış M; Kefeli M; Kan EK; Atmaca A; Çolak R Arch Endocrinol Metab; 2024; 68():e230422. PubMed ID: 39420875 [TBL] [Abstract][Full Text] [Related]
57. Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study. Zhou YL; Gao EL; Zhang W; Yang H; Guo GL; Zhang XH; Wang OC World J Surg Oncol; 2012 May; 10():67. PubMed ID: 22540396 [TBL] [Abstract][Full Text] [Related]
58. Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection. Chung YS; Kim JY; Bae JS; Song BJ; Kim JS; Jeon HM; Jeong SS; Kim EK; Park WC Thyroid; 2009 Mar; 19(3):241-6. PubMed ID: 19265495 [TBL] [Abstract][Full Text] [Related]
59. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a. Ryu YJ; Cho JS; Park MH; Yoon JH BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631 [TBL] [Abstract][Full Text] [Related]
60. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients. Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]